Liu Yong-Jun
Department of Immunology and Center for Cancer Immunology Research, University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA.
Annu Rev Immunol. 2005;23:275-306. doi: 10.1146/annurev.immunol.23.021704.115633.
Type 1 interferon-(alpha, beta, omega)-producing cells (IPCs), also known as plasmacytoid dendritic cell precursors (pDCs), represent 0.2%-0.8% of peripheral blood mononuclear cells in both humans and mice. IPCs display plasma cell morphology, selectively express Toll-like receptor (TLR)-7 and TLR9, and are specialized in rapidly secreting massive amounts of type 1 interferon following viral stimulation. IPCs can promote the function of natural killer cells, B cells, T cells, and myeloid DCs through type 1 interferons during an antiviral immune response. At a later stage of viral infection, IPCs differentiate into a unique type of mature dendritic cell, which directly regulates the function of T cells and thus links innate and adaptive immune responses. After more than two decades of effort by researchers, IPCs finally claim their place in the hematopoietic chart as the most important cell type in antiviral innate immunity. Understanding IPC biology holds future promise for developing cures for infectious diseases, cancer, and autoimmune diseases.
产生1型干扰素(α、β、ω)的细胞(IPC),也称为浆细胞样树突状细胞前体(pDC),在人类和小鼠外周血单个核细胞中占0.2%-0.8%。IPC呈现浆细胞形态,选择性表达Toll样受体(TLR)-7和TLR9,并专门在病毒刺激后快速分泌大量1型干扰素。在抗病毒免疫反应期间,IPC可通过1型干扰素促进自然杀伤细胞、B细胞、T细胞和髓样树突状细胞的功能。在病毒感染后期,IPC分化为一种独特类型的成熟树突状细胞,其直接调节T细胞的功能,从而连接先天免疫和适应性免疫反应。经过研究人员二十多年的努力,IPC最终在造血图谱中占据一席之地,成为抗病毒先天免疫中最重要的细胞类型。了解IPC生物学特性为开发治疗传染病、癌症和自身免疫性疾病的方法带来了未来的希望。